Clinical Trial Update: Study on Analgesia of GIC-1001 & GIC-1002 on Visceral Pain, Rectal Sensory Threshold Using the Barostat Method [Phase 1]

View source ↗

Summary

Phase 1 study evaluating the analgesic effects of GIC-1001 and GIC-1002 on visceral pain and rectal sensory thresholds using a barostat in participants with col…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cancer
• Colonic Disease

Drugs mentioned

• GIC-1001
• GIC-1002

Snippet

Sponsor: gicare Pharma Inc. | Conditions: Pain, Cancer | Phase 1 | Status: COMPLETED